Summary: IQVIA adds Early Phase and Phase IIb/III Trials

Why It Matters: The competitor is now highlighting specific clinical trial stages rather than general services. This suggests they are focusing more on drug proof-of-concept and late-stage regulatory navigation to attract specialized biotech clients.

What Changed:

• Replaced the general "Clinical Trials" section with "Early Phase Clinical Trials."
• Added a new section for "Phase IIb/III Trials" focusing on AI and enrollment.
• Renamed "Consulting" to "R&D Consulting."
• Reordered the R&D service list to prioritize early phase and late-stage trials over functional services.
• Added a link to their official Facebook page in the footer.